Amany Tawfik Selected Research

Macular Degeneration (Age-Related Maculopathy)

8/2021	Implication of N-Methyl-d-Aspartate Receptor in Homocysteine-Induced Age-Related Macular Degeneration.
2/2021	Exacerbation of AMD Phenotype in Lasered CNV Murine Model by Dysbiotic Oral Pathogens.
1/2021	N-Methyl-D-aspartate receptor activation, novel mechanism of homocysteine-induced blood-retinal barrier dysfunction.
1/2020	Homocysteine Induces Inflammation in Retina and Brain.
1/2020	Implication of Hyperhomocysteinemia in Blood Retinal Barrier (BRB) Dysfunction.
2/2016	Hyperhomocysteinemia disrupts retinal pigment epithelial structure and function with features of age-related macular degeneration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amany Tawfik Research Topics

Disease

12	Hyperhomocysteinemia 08/2021 - 07/2011
10	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 02/2009
6	Macular Degeneration (Age-Related Maculopathy) 08/2021 - 02/2016
6	Inflammation (Inflammations) 06/2021 - 02/2009
6	Ganglion Cysts (Ganglion) 05/2013 - 07/2011
4	Hyperglycemia 01/2019 - 11/2005
4	Gliosis 03/2015 - 03/2012
4	Retinal Diseases 03/2015 - 01/2012
3	Leukostasis 02/2020 - 06/2017
3	Iron Overload 01/2018 - 02/2004
2	Choroidal Neovascularization 08/2021 - 02/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 02/2013
2	Hypoxia (Hypoxemia) 02/2018 - 09/2014
2	Ischemia 09/2014 - 02/2013
2	Glaucoma 06/2014 - 03/2012
2	Optic Nerve Diseases (Optic Neuropathy) 03/2012 - 09/2011
2	Neoplasms (Cancer) 11/2010 - 10/2009
2	Diabetes Complications 11/2005 - 04/2005
1	Central Nervous System Diseases (CNS Diseases) 06/2021
1	Periodontal Diseases (Periodontal Disease) 02/2021
1	Infections 02/2021
1	Dysbiosis 02/2021
1	Vision Disorders (Hemeralopia) 01/2021
1	Vascular Remodeling 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Folic Acid Deficiency (Folic Acid Deficiencies) 01/2020
1	Pathologic Neovascularization 01/2020
1	Atherosclerosis 01/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Pathologic Processes 01/2019
1	Hyperuricemia 01/2019
1	Methylenetetrahydrofolate reductase deficiency 01/2016
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 06/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2013
1	Skin Diseases (Skin Disease) 03/2012
1	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2012
1	Hyperplasia 01/2012
1	Retinal Degeneration 01/2012
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2012
1	Hemochromatosis (Bronze Diabetes) 01/2012
1	Retinal Neovascularization 02/2011

Drug/Important Bio-Agent (IBA)

19	Retinaldehyde (Retinal)IBA 08/2021 - 02/2009
11	HomocysteineIBA 08/2021 - 07/2011
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2021 - 11/2010
3	CystathionineIBA 02/2018 - 07/2011
3	IronIBA 01/2018 - 02/2004
3	Proteins (Proteins, Gene)FDA Link 09/2014 - 07/2011
2	AlbuminsIBA 08/2021 - 01/2020
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2020 - 06/2017
2	Oxygen (Dioxygen)IBA 01/2020 - 02/2011
2	OccludinIBA 01/2020 - 09/2014
2	Streptozocin (Streptozotocin)FDA Link 01/2019 - 01/2019
2	EnzymesIBA 01/2019 - 02/2018
2	CytokinesIBA 01/2019 - 03/2015
2	Retinal Pigments (Pigments, Visual)IBA 02/2016 - 05/2013
2	Glial Fibrillary Acidic ProteinIBA 09/2014 - 05/2014
2	AntigensIBA 09/2014 - 01/2012
2	Iron-Regulatory Proteins (Iron-Responsive Element Binding Proteins)IBA 05/2014 - 01/2012
2	Cystathionine beta-Synthase (Serine Sulfhydrase)IBA 02/2013 - 03/2012
2	Endothelin-1 (Endothelin 1)IBA 11/2005 - 07/2004
1	NMDA receptor A1IBA 08/2021
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 08/2021
1	Fluorescein (Funduscein)FDA LinkGeneric 08/2021
1	Biological ProductsIBA 02/2021
1	Amino Acids FDA Link 01/2021
1	11,12-epoxy-5,8,14-eicosatrienoic acidIBA 01/2020
1	FructoseIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	VitaminsIBA 01/2020
1	Tight Junction ProteinsIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	BenzbromaroneIBA 01/2019
1	Allopurinol (Remid)FDA LinkGeneric 01/2019
1	Uric Acid (Urate)IBA 01/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 02/2018
1	MicroRNAs (MicroRNA)IBA 02/2018
1	ReninIBA 01/2018
1	Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA 12/2017
1	AntioxidantsIBA 12/2017
1	N-Me-Tyr1,D-Ala2,Asn8,Arg29-NHCH3-JI-38IBA 12/2017
1	Therapeutic UsesIBA 12/2017
1	Glucose (Dextrose)FDA LinkGeneric 06/2017
1	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 06/2017
1	pimonidazoleIBA 09/2014
1	CollagenIBA 05/2014
1	VimentinIBA 05/2014
1	Folic Acid (Vitamin M)FDA LinkGeneric 03/2012
1	FumaratesIBA 03/2012
1	HepcidinsIBA 01/2012
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2012
1	metal transporting protein 1 (ferroportin)IBA 01/2012
1	CaspasesIBA 09/2011
1	Caspase 3 (Caspase-3)IBA 07/2011
1	Arachidonate 12-Lipoxygenase (12 Lipoxygenase)IBA 02/2011
1	LigandsIBA 11/2010
1	Cisplatin (Platino)FDA LinkGeneric 11/2010
1	Glycoproteins (Glycoprotein)IBA 11/2010

Therapy/Procedure

1	Lasers (Laser) 02/2021
1	Ligation 02/2021